Amit Hazan
Stock Analyst at Goldman Sachs
(2.10)
# 2,792
Out of 5,182 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $55.11 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $9.95 | -74.87% | 5 | Nov 30, 2022 | |
| SKIN SkinHealth Systems | Maintains: Buy | $22 → $19 | $0.84 | +2,174.09% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $15.54 | -48.52% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $61.29 | +2.79% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $149.52 | +81.92% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $15.72 | +8.14% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $4.32 | +9,969.44% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $23.03 | +91.06% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $82.28 | -11.28% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $17.94 | +195.43% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $23.40 | +143.59% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $9.35 | +1.60% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $93.86 | +10.80% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $21.37 | +180.77% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $81.90 | +40.42% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $321.43 | -53.33% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $58.45 | -21.30% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $466.64 | -48.21% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $82.80 | +113.77% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $227.79 | -35.47% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $0.43 | +800.48% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $55.11
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $9.95
Upside: -74.87%
SkinHealth Systems
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $0.84
Upside: +2,174.09%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $15.54
Upside: -48.52%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $61.29
Upside: +2.79%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $149.52
Upside: +81.92%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $15.72
Upside: +8.14%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $4.32
Upside: +9,969.44%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $23.03
Upside: +91.06%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $82.28
Upside: -11.28%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $17.94
Upside: +195.43%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $23.40
Upside: +143.59%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $9.35
Upside: +1.60%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $93.86
Upside: +10.80%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $21.37
Upside: +180.77%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $81.90
Upside: +40.42%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $321.43
Upside: -53.33%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $58.45
Upside: -21.30%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $466.64
Upside: -48.21%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $82.80
Upside: +113.77%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $227.79
Upside: -35.47%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $0.43
Upside: +800.48%